Search

Geron Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

1.55 2.65

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.44

Max

1.54

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-13M

-17M

Pardavimai

5.6M

57M

Pelnas, tenkantis vienai akcijai

-0.02

Pelno marža

-29.019

Darbuotojai

258

EBITDA

-16M

-12M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+184.87% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

162M

983M

Ankstesnė atidarymo kaina

-1.1

Ankstesnė uždarymo kaina

1.55

Naujienos nuotaikos

By Acuity

75%

25%

314 / 340 reitingas Healthcare

Geron Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-24 23:46; UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

2026-08-21 19:46; UTC

Geron Corp shares are lower today, reflecting broader market trends, despite remaining above the 20-day moving average and near the upper end of the one-month range.

2026-08-20 23:06; UTC

Geron Corp shares are lower in after-market hours, showing notable volatility while remaining above their 20-day moving average and near the month's upper range.

2026-08-19 19:26; UTC

Geron Corp shares are higher today, continuing a three-day upward trend. The stock remains above its 20-day moving average, indicating strong market positioning.

2026-08-18 21:03; UTC

News

Geron Corporation's shares are lower in after-market trading following the grant of stock options to new employees at an exercise price of $1.53.

2026-08-17 23:56; UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

2026-08-14 20:02; UTC

Macro Event

Geron Corp shares are lower today amid broader market declines and disappointing U.S. retail sales data, reflecting negative investor sentiment.

2026-08-13 23:36; UTC

Shares of Geron Corp are trading higher in after-market hours, reflecting a strong performance backdrop despite no specific news identified.

2026-08-12 23:36; UTC

Geron Corp shares are higher in after-market trading, reflecting an upward move since Wednesday's close. The stock remains above its 20-day moving average.

2026-08-11 22:52; UTC

Geron Corp shares are lower in after-market trading with no specific news identified. Broader market sentiment was pressured by rising crude oil prices.

2026-08-10 23:06; UTC

Geron Corp shares are higher in after-market hours, reflecting a gain despite mixed market sentiment and geopolitical tensions affecting global energy markets.

2026-08-07 20:03; UTC

Geron Corp shares are sharply lower during Friday's trading session, reflecting a broader market decline with no specific news identified to explain the movement.

2026-08-06 23:06; UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Thursday's close amid a strong recent performance backdrop.

2026-08-05 23:31; UTC

Geron Corp shares are lower in after-market hours, continuing a decline that began during regular trading, with no specific news identified.

2026-08-04 23:36; UTC

Geron Corp shares are lower in after-market trading, nearing the bottom of their one-month range and below the 20-day moving average.

2026-08-03 23:06; UTC

Geron Corp shares are lower in after-market hours, continuing a steady decline since Monday's close and remaining below the 20-day moving average.

2026-07-31 20:02; UTC

Geron Corp shares are lower as the Biotechnology sub-sector declines. The stock pulled back from an earlier session high, finishing below its 20-day moving average.

2026-07-30 20:56; UTC

Geron Corp shares are higher in after-market hours, influenced by positive corporate earnings amid broader market uncertainty following the Federal Reserve's interest rate decision.

2026-07-29 19:32; UTC

Macro Event

Geron Corp shares are lower as market volatility rises following the Federal Reserve's interest rate decision amid ongoing economic growth and inflation concerns.

2026-07-28 18:51; UTC

Shares of Geron Corp are lower today amid broader market volatility and uncertainty regarding Federal Reserve decisions. The stock declined since Monday's close.

2026-07-27 23:16; UTC

Geron Corp shares are lower in after-market trading, despite earlier gains, with no specific company news driving the decline.

2026-07-24 19:46; UTC

Geron Corp shares are lower in Friday's session amid broader market volatility and uncertainty from fluctuating oil prices and new U.S. tariffs.

2026-07-23 10:11; UTC

Shares of Geron Corp are higher in pre-market hours, trading above their 20-day moving average. No specific company news was identified.

2026-07-22 18:51; UTC

Geron Corp shares are lower today amid broader market trends, as crude oil prices surge due to geopolitical tensions.

2026-07-21 23:41; UTC

Geron Corp shares are lower in after-market trading, declining to their lowest point since Tuesday's close. No specific news was identified to explain the drop.

2026-07-20 23:56; UTC

Geron Corp shares are lower in after-market hours, continuing a decline since Monday's close amid broader market uncertainties and a drop in the leading economic index.

Akcijų palyginimas

Kainos pokytis

Geron Corp Prognozė

Kainos tikslas

By TipRanks

184.87% į viršų

12 mėnesių prognozė

Vidutinis 4.33 USD  184.87%

Aukščiausias 6 USD

Žemiausias 3 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Geron Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

3

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

314 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat